[صفحه اصلی ]   [Archive] [ English ]  
جستجو در پایگاه

جستجوی پیشرفته
..
نظرسنجی
مطالب کدام بخش سایت بیشتر مورد نیاز شماست؟
پرسش و پاسخ
جشنواره شهید هدایت
کلینیک تخصصی دندانپزشکی
مجله علمی
نمایشگاه کتاب
نمایشگاه مواد و تجهیزات دندانپزشکی
نیازمندیها
   
..
:: دوره 4، شماره 4 - ( مجموعه مقالات پاتولوژی فک و دهان 1390 ) ::
جلد 4 شماره 4 صفحات 0-0 برگشت به فهرست نسخه ها
Comparative immunohistochemical study of ameloblastoma and ameloblastic carcinoma
چکیده:   (3100 مشاهده)
Objective

 Ameloblastic carcinoma combines the histologic features of ameloblastoma with cytologic atypia, regardless of whether it has metastasized. Because of its rarity, there are few immunoprofile studies of ameloblastic carcinoma and few comparative studies of ameloblastic carcinoma and ameloblastoma. In this study, we compared the expression levels of cytokeratins (CKs), matrix metalloproteinases (MMPs), and Ki-67 between ameloblastoma and ameloblastic carcinoma, and assessed the usefulness of these markers for differentiating the tumors.

Study design

 We assessed CK7, CK14, CK18, CK19, MMP-2, MMP-9, and Ki-67 expression by immunohistochemistry in 10 cases of ameloblastoma and 7 cases of ameloblastic carcinoma and then compared expression patterns between the 2 groups.

Results

 Immunostaining for CK14 and CK19 was diffuse and strongly positive in both tumor types, but staining for CK7 was focally positive in only 1 case of ameloblastoma and absent in all cases of ameloblastic carcinoma. However, there was a significant difference in CK18 expression between the 2 tumors (P = .000). Whereas 80% of ameloblastomas showed negative reactivity for CK18, most cases of ameloblastic carcinomas showed a moderate to strong intensity of immunostaining for CK18. Regarding the expression of MMPs, there were significant differences in parenchymal MMP-2 and stromal MMP-9 expression between the 2 tumors. Compared to ameloblastoma, ameloblastic carcinoma showed significantly strong expression of MMP-2 in parenchymal cells (P = .001) and MMP-9 in stromal cells (P = .013). However, there were no differences in MMP-2 expression of stromal cells and MMP-9 expression of parenchymal cells between ameloblastoma and ameloblastic carcinoma. The mean Ki-67 labeling index (LI) of ameloblastic carcinomas was 17.21%, which was significantly higher than that of ameloblastomas (3.57% P = .002).

Conclusions

 The significant expression of CK18, parenchymal MMP-2, stromal MMP-9, and Ki-67 could provide useful markers for differentiating ameloblastic carcinoma from ameloblastoma.


  Source: Journal of oral surgery, oral Medicine, Oral Pathology

  Full text

     
نوع مطالعه: پژوهشي | موضوع مقاله: پاتولوزی دهان، فک و صورت
دریافت: 1391/2/13 | انتشار: 1390/10/25
ارسال نظر درباره این مقاله
نام کاربری یا پست الکترونیک شما:

CAPTCHA


XML   English Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Yoon H, Jo B, shin W, Cho Y, Lee J, Hong S et al . Comparative immunohistochemical study of ameloblastoma and ameloblastic carcinoma. 3 2012; 4 (4)
URL: http://idai.ir/article-1-480-fa.html

Comparative immunohistochemical study of ameloblastoma and ameloblastic carcinoma. 1. 1390; 4 (4)

URL: http://idai.ir/article-1-480-fa.html



بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.
دوره 4، شماره 4 - ( مجموعه مقالات پاتولوژی فک و دهان 1390 ) برگشت به فهرست نسخه ها
جامعه اسلامی دندانپزشکان Islamic Dental Association of IRAN

کلیه حقوق سایت متعلق به جامعه اسلامی دندانپزشکان ایران است. تماس با ما

Persian site map - English site map - Created in 0.04 seconds with 37 queries by YEKTAWEB 4710